Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

167 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours.
Delord JP, Pierga JY, Dieras V, Bertheault-Cvitkovic F, Turpin FL, Lokiec F, Lochon I, Chatelut E, Canal P, Guimbaud R, Mery-Mignard D, Cornen X, Mouri Z, Bugat R. Delord JP, et al. Among authors: lokiec f. Br J Cancer. 2005 Mar 14;92(5):820-6. doi: 10.1038/sj.bjc.6602354. Br J Cancer. 2005. PMID: 15756252 Free PMC article. Clinical Trial.
Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study.
Brain EG, Rezai K, Weill S, Gauzan MF, Santoni J, Besse B, Goupil A, Turpin F, Urien S, Lokiec F. Brain EG, et al. Among authors: lokiec f. Cancer Chemother Pharmacol. 2007 Aug;60(3):375-81. doi: 10.1007/s00280-006-0373-8. Epub 2006 Nov 15. Cancer Chemother Pharmacol. 2007. PMID: 17106751 Clinical Trial.
Phase I population pharmacokinetics of irofulven.
Urien S, Alexandre J, Raymond E, Brain E, Smith S, Shah A, Cvitkovic E, Lokiec F. Urien S, et al. Among authors: lokiec f. Anticancer Drugs. 2003 Jun;14(5):353-8. doi: 10.1097/00001813-200306000-00005. Anticancer Drugs. 2003. PMID: 12782941 Clinical Trial.
167 results